Q4 FY2025 · ended Dec 31, 2025 · Revenue $0, -100.0% YoY · Filed Feb 19, 2026
Praxis Precision Medicines, Inc. (PRAX) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$77.8 million. As of Jun 30, 2026 it held $1.4 billion in cash and investments and $1.1 million in total debt.
Revenue
$0
-100.0% vs year-ago quarter
Net income
$-83.72M
-17.7% vs year-ago quarter
Operating cash flow
$-77.54M
-41.8% vs year-ago quarter
Free cash flow
$-77.79M
-42.1% vs year-ago quarter
EPS
$-2.87
+13.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
27.92M
+32.7% vs year-ago quarter
Net cash
$1.37B
Q2 FY2026
Operating margin
-857.0%
Q4 FY2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1689548
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $0 | $0 | $0 |
| Operating income | -$96.9M | -$105.9M | -$97.0M | -$78.4M | -$76.1M |
| Net income | -$83.7M | -$92.6M | -$88.9M | -$73.9M | -$71.1M |
| Diluted EPS | -$2.87 | -$3.20 | -$3.49 | -$3.36 | -$3.31 |
| Operating cash flow | -$77.5M | -$86.2M | -$76.3M | -$65.1M | -$54.7M |
| Free cash flow | -$77.8M | -$86.2M | -$76.3M | -$65.1M | -$54.7M |
| Total assets | $1.4B | $1.5B | $937.9M | $396.4M | $452.8M |
| Total liabilities | $49.1M | $50.2M | $59.8M | $52.9M | $48.6M |
| Stockholders' equity | $1.3B | $1.4B | $878.1M | $343.5M | $404.2M |
| Cash and investments | $1.4B | $1.4B | $926.1M | $389.2M | $446.6M |
| Total debt | $1.1M | $1.4M | $110,000 | $436,000 | $755,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Other events
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 2, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 22, 2026 | Jun 22, 2026 |
All 511 Praxis Precision Medicines, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.